Dr. Christina Cho highlights the Adult Stem Cell Transplant and Cellular Therapy Program for its innovative research and compassionate, multidisciplinary team. Dr ...

FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry age-related ...

In the United States, age-related macular degeneration is a leading cause of irreversible vision loss in people who are 60 and older. Subscribe to our newsletter for the latest sci-tech news updates.

Stem cell therapy has emerged as a groundbreaking treatment option for corneal injuries, offering hope to individuals suffering from severe damage to the cornea. Cornea is the transparent, dome-shaped ...

The stem cell therapy market size is expected to be worth USD 59.70 billion by 2035, increasing from USD 18.13 billion in ...

A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is ...

Tissue-specific “adult” stem cells that are capable of both self-renewal and specialized tissue repair reside in certain tissues, such as the epidermis, limbal tissue of the eye, skeletal muscle, and ...

The Hoskinson Government and Policy Center proudly supports the Stem Cell Freedom Act, a bill expanding access to life-saving stem cell treatments ...

Dr. David Alanis, a San Antonio-born physician who practiced sports medicine and pain management and was an alumnus of Central Catholic High School and St. Mary's University, died Aug. 22 of heart ...